EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function
NCT00302497
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplant
Interventions
DRUG:
basiliximab
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre